← back to search

Suzanne Pickering

King's College London · GB
Area of research
Infectious Diseases · Virology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, SARS-CoV-2 detection and testing, COVID-19 Clinical Research Studies, and HIV Research and Treatment.
h-index
24
citations
3,630
works
48
NIH funding
primary concept
email

Recent publications

The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance
Journal of Virology 2022cited by 70position: middledoi
A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination
Cell Reports 2022cited by 48position: middledoi
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
Immunity 2021cited by 167position: middledoi
The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2
Journal of Virology 2021cited by 160position: middledoi
Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study
The Lancet Microbe 2021cited by 156position: firstdoi
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
Nature Microbiology 2021cited by 116position: middledoi
Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation
PLoS ONE 2021cited by 40position: middledoi
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Nature Microbiology 2020cited by 1,380position: middledoi
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings
PLoS Pathogens 2020cited by 120position: firstdoi
HIV-1 Vpu Downregulates Tim-3 from the Surface of Infected CD4 <sup>+</sup> T Cells
Journal of Virology 2020cited by 37position: middledoi
HIV-1 Vpu Mediates HLA-C Downregulation
Cell Host & Microbe 2016cited by 138position: middledoi
Serine Phosphorylation of HIV-1 Vpu and Its Binding to Tetherin Regulates Interaction with Clathrin Adaptors
PLoS Pathogens 2015cited by 67position: middledoi
Retroviral Retention Activates a Syk-Dependent HemITAM in Human Tetherin
Cell Host & Microbe 2014cited by 59position: middledoi
Innate Sensing of HIV-1 Assembly by Tetherin Induces NFκB-Dependent Proinflammatory Responses
Cell Host & Microbe 2012cited by 266position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Stuart J. D. Neil · Guy's Hospital8 papers (2012–2022)Rui Pedro Galão · King's College London5 papers (2012–2022)María José Lista · King's College London3 papers (2021–2022)Katie J. Doores · King's College London3 papers (2021–2022)Tonya Kueck · Max Planck Institute for the History of Science2 papers (2012–2015)Helena Winstone · University of Pennsylvania2 papers (2021–2022)Michael H. Malim · King's College London2 papers (2021–2022)Luke B. Snell · King's College London2 papers (2021–2022)Gaia Nebbia · Guy's and St Thomas' NHS Foundation Trust2 papers (2021–2022)Chad M. Swanson · King's College School2 papers (2021–2022)Wilhelm Furnon · Université Claude Bernard Lyon 11 papers (2022–2022)Jonathan Richard · McGill University Health Centre1 papers (2020–2020)Jeffrey Seow · King's College London1 papers (2022–2022)Nicolás M. Suárez · The Ohio State University1 papers (2022–2022)Daniel E. Kaufmann · Centre Hospitalier de l’Université de Montréal1 papers (2020–2020) · 1 papers (2016–2016)Peter Cherepanov · The Francis Crick Institute1 papers (2022–2022)Massimo Palmarini · University of Glasgow1 papers (2022–2022)Jeffrey D. Lifson · Center for Cancer Research1 papers (2016–2016)Beatrice H. Hahn · University of Pennsylvania1 papers (2016–2016)